Get the Stockscreener App
1.91
1.87%
0.035
Q 32 Bio Inc stock is traded at $1.91, with a volume of 91,885.
It is up +1.87% in the last 24 hours and down -14.73% over the past month.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
See More
Previous Close:
$1.875
Open:
$1.87
24h Volume:
91,885
Relative Volume:
0.07
Market Cap:
$23.30M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.05%
1M Performance:
-14.73%
6M Performance:
-25.68%
1Y Performance:
-95.05%
1-Day Range:
$1.7907
$1.98
1-Week Range:
$1.7304
$2.10
52-Week Range:
$1.345
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio Inc
Sector
Industry
Phone
781-999-0232
Address
830 WINTER STREET, WALTHAM
Compare QTTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.91 | 24.88M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Feb-11-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-11-24 | Downgrade | Guggenheim | Buy → Neutral |
| Dec-11-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-24-24 | Initiated | Raymond James | Strong Buy |
| Sep-11-24 | Initiated | Wells Fargo | Overweight |
| Jun-17-24 | Initiated | Guggenheim | Buy |
| May-21-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Oppenheimer | Outperform |
| Apr-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-28-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-22-22 | Reiterated | BTIG Research | Neutral |
| Feb-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-22-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-21 | Initiated | Stifel | Hold |
| Dec-14-20 | Resumed | H.C. Wainwright | Buy |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| Mar-16-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-24-20 | Initiated | Chardan Capital Markets | Buy |
| Nov-01-19 | Initiated | Oppenheimer | Perform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Apr-12-19 | Initiated | Evercore ISI | Outperform |
View All
Q 32 Bio Inc Stock (QTTB) Latest News
Price action breakdown for Q32 Bio Inc.2025 Pullback Review & Risk Controlled Daily Plans - Newser
Can Q32 Bio Inc. Overcome Bearish SentimentExit Point & Verified Momentum Stock Watchlist - news-j.co.kr
Price Channel Expanding on Q32 Bio Inc.’s ChartWeekly Volume Report & Free Accurate Trade Setup Notifications - kangso.co.kr
Will a bounce in Q32 Bio Inc. offer an exitJuly 2025 Big Picture & High Return Stock Watch Alerts - Newser
Has Q32 Bio Inc. formed a bullish divergence2025 Investor Takeaways & Capital Efficiency Focused Strategies - Newser
Real time scanner hits for Q32 Bio Inc. explainedJuly 2025 Technicals & Safe Capital Growth Plans - Newser
What’s next for Q32 Bio Inc. stock priceJuly 2025 Review & Low Risk High Win Rate Stock Picks - Newser
Does Q32 Bio Inc. qualify in momentum factor screening2025 Market WrapUp & Long-Term Capital Growth Strategies - Newser
Building trade automation scripts for Q32 Bio Inc.Weekly Gains Summary & Verified Entry Point Signals - Newser
How Q32 Bio Inc. stock reacts to Fed policy changesBreakout Watch & Weekly High Return Stock Forecasts - Newser
Q32 Bio Inc. stock daily chart insights2025 Top Gainers & Reliable Volume Spike Alerts - Newser
How to use Fibonacci retracement on Q32 Bio Inc.Weekly Trading Summary & Free Weekly Watchlist of Top Performers - Newser
Chart based analysis of Q32 Bio Inc. trendsQuarterly Market Review & Consistent Profit Trading Strategies - Newser
Published on: 2025-08-19 14:35:54 - Newser
Should you hold or exit Q32 Bio Inc. now2025 Short Interest & Safe Swing Trade Setup Alerts - Newser
Sector ETF performance correlation with Q32 Bio Inc.Buy Signal & Free Accurate Trade Setup Notifications - Newser
Q32 Bio Inc. stock outlook for YEAR2025 Short Interest & Real-Time Volume Spike Alerts - Newser
Is Q32 Bio Inc. stock bottoming outTrade Analysis Report & Verified Stock Trade Ideas - Newser
Drawdown in Q32 Bio Inc. May Be Nearing End2025 EndofYear Setup & Daily Volume Surge Trade Alerts - 선데이타임즈
Using fundamentals and technicals on Q32 Bio Inc.2025 Major Catalysts & Fast Gain Swing Trade Alerts - Newser
Will Q32 Bio Inc. rebound enough to break evenJuly 2025 Trends & AI Powered Buy and Sell Recommendations - Newser
Can a trend reversal in Q32 Bio Inc. lead to recoveryJuly 2025 Final Week & Safe Entry Trade Signal Reports - Newser
Earnings visualization tools for Q32 Bio Inc.Market Risk Summary & Safe Entry Trade Signal Reports - Newser
Q32 Bio Inc. (NASDAQ:QTTB) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Using data tools to time your Q32 Bio Inc. exitEntry Point & Daily Technical Forecast Reports - Newser
Q32 Bio Inc. Advances Alopecia Areata Treatment with Phase 2a Trial of Bempikibart - MSN
Should you wait for a breakout in Q32 Bio Inc.Earnings Risk Summary & Expert Curated Trade Ideas - Newser
Why Q32 Bio Inc. stock attracts strong analyst attentionJobs Report & Capital Efficiency Focused Ideas - 선데이타임즈
Intrinsic Value of Q32 Bio Inc. Stock: Is It Undervalued or OvervaluedJuly 2025 Institutional & Fast Entry and Exit Trade Plans - Newser
What earnings revisions data tells us about Q32 Bio Inc.Risk Management & Weekly Watchlist for Consistent Profits - Newser
Can trapped investors hope for a rebound in Q32 Bio Inc.Oil Prices & Daily Momentum Trading Reports - Newser
What’s the profit margin of Q32 Bio Inc.Market Risk Report & Daily Risk Controlled Trade Plans - 선데이타임즈
Q 32 Bio Inc Stock (QTTB) Financials Data
There is no financial data for Q 32 Bio Inc (QTTB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Q 32 Bio Inc Stock (QTTB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer |
Oct 11 '24 |
Option Exercise |
3.12 |
4,574 |
14,271 |
17,874 |
| Violette Shelia M. | Chief Scientific Officer |
Oct 08 '24 |
Option Exercise |
3.12 |
13,300 |
41,496 |
13,300 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):